Please login to the form below

Not currently logged in
Email:
Password:

Cancer Research UK

This page shows the latest Cancer Research UK news and features for those working in and with pharma, biotech and healthcare.

NICE says OK to Keytruda for bladder cancer via the CDF

NICE says OK to Keytruda for bladder cancer via the CDF

According to Cancer Research UK, urothelial cancer is the most common form of bladder cancer and accounts for over 90% of cases and it is the only top ten cancer where ... Louise Houson, UK managing director for MSD, said: “MSD is really pleased that

Latest news

  • NICE backs EUSA's RCC treatment Fotivda NICE backs EUSA's RCC treatment Fotivda

    NICE backs EUSA's RCC treatment Fotivda. The UK’s cost-effectiveness watchdog recommends its first-line use. ... According to Cancer Research UK, around 12 people in the UK die every day of kidney cancer, with RCC being the most common form of kidney

  • Merck forges closer ties with Cancer Research UK Merck forges closer ties with Cancer Research UK

    Merck forges closer ties with Cancer Research UK. Will partake in three research projects covering hit discovery to preclinical candidate selection. ... Researchers at Merck KGaA will join forces with scientists at Cancer Research UK for an early-stage

  • GSK to replace R&D head Vallance with Calico’s Hal Barron GSK to replace R&D head Vallance with Calico’s Hal Barron

    San Francisco and GSK’s research hub in Stevenage in the UK. ... Barron’s track record in cancer research gives another indication that GSK is planning a renewed push into oncology after selling off the bulk of its assets in this category to

  • Europe’s cancer drug regulation is ‘broken’, claims study Europe’s cancer drug regulation is ‘broken’, claims study

    Europe’ s cancer drug regulation is ‘ broken’, claims study. Suggests EMA oncology approvals could lead to wasted funds and patient harm. ... Meanwhile, medical charity Cancer Research UK said the findings were “useful”but director of policy

  • Biotecnol taps into Cancer Research UK network for first trial Biotecnol taps into Cancer Research UK network for first trial

    Biotecnol taps into Cancer Research UK network for first trial. New drug hoped to have broad activity across multiple tumour types. ... UK company Biotecnol Ltd has formed an alliance with Cancer Research UK to trial its lead drug, a new form of cancer

More from news
Approximately 13 fully matching, plus 118 partially matching documents found.

Latest Intelligence

  • Communicating health messages Communicating health messages

    Consider this impactful infographic from Cancer Research UK:. Now take a look at how such comparisons are normally presented in the media. ... them? They are human too. Source: Cancer Research UK. How data is framed can incite behaviour change .

  • EATRIS and the new age of partnering EATRIS and the new age of partnering

    In a display of its global ambition, EATRIS is joining with Cancer Research UK to bring representatives of the US's National Cancer Institute to a workshop in Brussels in October ... to happen so we have the good political support underlined with

  • Communiqué Awards digital publication Communiqué Awards digital publication

    See which healthcare communications programmes made a real difference to health outcomes with the Communiqué Awards digital publication.

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

  • Glythera strengthens its scientific advisory board and appoints CSO Glythera strengthens its scientific advisory board and appoints CSO

    Glythera strengthens its scientific advisory board and appoints CSO. Dr Robert Lutz and Dr Jon Roffey join the UK biotech. ... Additionally, Dr Jon Roffey joins Glythera ’s scientific advisory board (SAB) from Cancer Research Technology (CRT), Cancer

  • Storm Therapeutics strengthens its board Storm Therapeutics strengthens its board

    Workman currently serves The Institute of Cancer Researc h as its president and chief executive officer and has formerly served as head of the division of cancer therapeutics at Cancer Research ... world class cancer institute and being a founder of

  • Cancer Research UK's Karen Vousden to join BMS board Cancer Research UK's Karen Vousden to join BMS board

    Cancer Research UK's Karen Vousden to join BMS board. She will also serve on the pharma firm's Science and Technology Committee. ... Cancer Research UK's Karen Vousden is set to join Bristol-Myers Squibb’s board of directors in January.

  • Sophie Adlard joins J+D Consulting as a business analyst Sophie Adlard joins J+D Consulting as a business analyst

    Sophie Adlard joins J D Consulting as a business analyst. She brings experience from Cancer Research UK, where she was a PhD student. ... market research and forecasting projects going forward.”.

  • Hollingsworth leaves cancer charity for ABPI Hollingsworth leaves cancer charity for ABPI

    Andrew Hollingsworth is to leave the third sector to join industry, moving from Cancer Research UK to the Association of the British Pharmaceutical Industry (ABPI). ... He leaves his role as public affairs manager at Cancer Research UK.

More from appointments
Approximately 1 fully matching, plus 7 partially matching documents found.

Latest from PMHub

  • Why is the UK lagging behind the rest of Europe in cancer survival?

    Why is the UK lagging behind the rest of Europe in cancer survival? ... Say Communications, London healthcare PR agency, discusses the latest technologies that will improve cancer survival rates in UK.

  • World Cancer Day and the role of people-centred care

    Overview on Patient Centricity in Cancer Care. Front Pharmacol 2017; 8: 1-12. ... BMJ Innov 2017; 3(2): 76-83. World Cancer Day. Available at: . Accessed February 2018. Cancer Research UK. Available at: . Accessed February 2018.

  • Caring for prostate cancer patients

    Cancer Research UK estimates that  men in the UK have a 1 in 8 chance of developing prostate cancer at some point in their lives. ... From a personal perspective, I’ ve watched my grandfather receive his diagnosis of prostate cancer.

  • When is sun safety doing more harm than good?

    New figures from  Cancer Research UK warn that people over 65 are around seven times more likely to develop malignant melanoma - a type of skin cancer - compared to 40 years ago. ... Thankfully campaigns from charities such as Cancer Research UK that

  • World Cancer Day and the role of people-centred care

    Overview on Patient Centricity in Cancer Care. Front Pharmacol 2017; 8: 1-12. ... BMJ Innov 2017; 3(2): 76-83. World Cancer Day. Available at: . Accessed February 2018. Cancer Research UK. Available at: . Accessed February 2018.

More from PMHub
Approximately 2 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Weber Shandwick

At Weber Shandwick, engagement has always been the cornerstone of health communications.We make health matter. Health is a basic human...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics